Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its ...
manilatimes42m
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-(L)1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival Foll ...
Taiwan News56m
SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
Encouraging results from Phase 1/2 study of mirdametinib in pediatric patients with low-grade glioma also to be presented in oral session at SNO – STAMFORD, Conn., (GLOBE NEWSWIRE) -- SpringWorks ...
Le Lézard39m
SWITCH Maritime Advances First Liquid Hydrogen Vessel Project in the US
SWITCH Maritime, the US shipowner that successfully launched the first H2 powered ferry in the US, is pushing ahead with its next industry-leading, zero-emission vessel project. In collaboration with ...